Literature DB >> 23128435

MicroRNA-125b expression in gastric adenocarcinoma and its effect on the proliferation of gastric cancer cells.

Zhao-Xu Yang1, Cheng-Yi Lu, Yan-Ling Yang, Ke-Feng Dou, Kai-Shan Tao.   

Abstract

MicroRNAs exert regulatory effects on a number of genes, thereby contributing to both physiological and pathological processes. The functions of microRNAs in tumorigenesis are becoming increasingly clear. In the present study, we investigated the role of microRNA-125b (miR‑125b), previously implicated in prostate and breast cancer, in gastric cancer, particularly regarding proliferation and apoptosis of gastric cancer cells. The expression of miR‑125b was measured in 50 samples of gastric cancer tissues and corresponding para-cancerous tissues by real-time PCR. The levels of miR‑125b expression in the gastric cancer tissues were significantly higher compared to the adjacent normal tissues (P<0.05). To begin to understand how the increased expression of miR‑125b may promote gastric cancer, the miR‑125b mimic was transfected into the gastric cancer cell line, HGC‑27, for the determination of proliferation (CCK8) and apoptosis (Annexin V) by flow cytometry. The results demonstrated that the proliferation significantly increased and apoptosis significantly decreased in the HGC‑27 cells following transfection with the miR‑125b mimic, compared to the untreated and scramble‑treated controls (P<0.05). Thus, miR‑125b may act as an oncogene in gastric cancer by dysregulating gastric cell proliferation and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23128435     DOI: 10.3892/mmr.2012.1156

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  9 in total

Review 1.  MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer.

Authors:  C Jiang; X Chen; M Alattar; J Wei; H Liu
Journal:  Cancer Gene Ther       Date:  2015-05-22       Impact factor: 5.987

2.  MiR-300 regulate the malignancy of breast cancer by targeting p53.

Authors:  Xiao-Heng Xu; Da-Wei Li; Hui Feng; Hong-Mei Chen; Yan-Qiu Song
Journal:  Int J Clin Exp Med       Date:  2015-05-15

3.  miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway.

Authors:  Ismael Riquelme; Oscar Tapia; Pamela Leal; Alejandra Sandoval; Matthew G Varga; Pablo Letelier; Kurt Buchegger; Carolina Bizama; Jaime A Espinoza; Richard M Peek; Juan Carlos Araya; Juan Carlos Roa
Journal:  Cell Oncol (Dordr)       Date:  2015-10-12       Impact factor: 6.730

4.  Identification of a Novel Prognostic Signature for Gastric Cancer Based on Multiple Level Integration and Global Network Optimization.

Authors:  Lin Cui; Ping Wang; Dandan Ning; Jing Shao; Guiyuan Tan; Dajian Li; Xiaoling Zhong; Wanqi Mi; Chunlong Zhang; Shizhu Jin
Journal:  Front Cell Dev Biol       Date:  2021-04-12

5.  Predicting miRNA-Disease Association Based on Modularity Preserving Heterogeneous Network Embedding.

Authors:  Wei Peng; Jielin Du; Wei Dai; Wei Lan
Journal:  Front Cell Dev Biol       Date:  2021-06-10

6.  miR-125b Suppresses Proliferation and Invasion by Targeting MCL1 in Gastric Cancer.

Authors:  Shihua Wu; Feng Liu; Liming Xie; Yaling Peng; Xiaoyuan Lv; Yaping Zhu; Zhiwei Zhang; Xiusheng He
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

7.  MiR-493 suppresses the proliferation and invasion of gastric cancer cells by targeting RhoC.

Authors:  Wenhua Zhou; Chi Zhang; Hao Jiang; Zhiwei Zhang; Liming Xie; Xiusheng He
Journal:  Iran J Basic Med Sci       Date:  2015-10       Impact factor: 2.699

8.  The functional mechanism of miR-125b in gastric cancer and its effect on the chemosensitivity of cisplatin.

Authors:  Xinyue Zhang; Jie Yao; Kai Guo; Hu Huang; Siyuan Huai; Rui Ye; Baolong Niu; Tiannan Ji; Weidong Han; Jianxiong Li
Journal:  Oncotarget       Date:  2017-12-14

Review 9.  Vitamin D modulation and microRNAs in gastric cancer: prognostic and therapeutic role.

Authors:  Elena Gallardo Martin; Antia Cousillas Castiñeiras
Journal:  Transl Cancer Res       Date:  2021-06       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.